What are the possible causes and recommended work‑up for a patient presenting with hyperpigmented (black) skin and diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Primary Adrenal Insufficiency (Addison's Disease) Must Be Ruled Out Immediately

The combination of hyperpigmentation and diarrhea is a classic presentation of primary adrenal insufficiency (PAI), which is a life-threatening condition requiring urgent diagnosis and treatment. 1

Immediate Diagnostic Approach

The diagnosis of PAI should be considered in all patients presenting with diarrhea and hyperpigmentation 1. This is a medical emergency that can rapidly progress to adrenal crisis with collapse and hypotension.

Initial Laboratory Work-Up (Do Not Delay Treatment)

Obtain these tests immediately:

  • Paired serum cortisol and plasma ACTH - This is the definitive diagnostic test 1

    • Serum cortisol <250 nmol/L with elevated ACTH is diagnostic of PAI
    • Serum cortisol <400 nmol/L with elevated ACTH raises strong suspicion
  • Basic metabolic panel looking for:

    • Hyponatremia (present in 90% of cases) 1
    • Hyperkalemia (present in ~50% of cases)
    • Hypoglycemia (especially in children)
  • Additional supportive labs:

    • Complete blood count (may show anemia, eosinophilia, lymphocytosis)
    • Plasma renin activity (elevated)
    • Serum aldosterone (low)
    • DHEAS (low)

Critical Management Point

Treatment of suspected acute adrenal insufficiency should never be delayed by diagnostic procedures 1. If clinical suspicion is high, start hydrocortisone immediately after drawing blood for cortisol and ACTH.

Establishing Etiology After Diagnosis

Once PAI is confirmed, determine the underlying cause:

  1. Measure 21-hydroxylase (anti-adrenal) autoantibodies - most common cause is autoimmune 1

  2. If antibodies are negative, obtain CT imaging of adrenals 1

  3. In male patients, assay very long-chain fatty acids to check for adrenoleukodystrophy 1

  4. In children/young adults with other features (hypoparathyroidism, candidiasis), consider APS-1 syndrome 1

Alternative Diagnoses to Consider

While PAI is the most critical diagnosis to exclude, other conditions can present with hyperpigmentation and diarrhea:

Cronkhite-Canada Syndrome

A rare non-hereditary disorder presenting with diffuse GI polyposis, diarrhea, and ectodermal changes including skin hyperpigmentation, alopecia, and nail dystrophy 2. Typically affects patients >50 years old. Requires endoscopic evaluation if PAI is excluded.

Pediatric Presentation

In infants presenting in the first 2 months of life with chronic diarrhea and distinct hyperpigmentation patterns, consider a rare autosomal recessive syndrome with abnormal hair and possible facial dysmorphism 3. This requires intestinal biopsy and genetic evaluation.

Key Clinical Pitfalls

  • Do not wait for the "classic" combination of hyponatremia and hyperkalemia - sodium is often only marginally reduced and potassium is elevated in only half of patients 1

  • Exogenous steroid use (oral prednisolone, dexamethasone, inhaled fluticasone) can confound cortisol interpretation 1

  • In patients with severe vomiting, hypokalemia and alkalosis may be present instead of hyperkalemia 1

  • Hyperpigmentation in PAI is caused by elevated ACTH stimulating melanocytes, particularly visible in sun-exposed areas, skin creases, and mucous membranes

Confirmatory Testing if Initial Results Equivocal

If initial cortisol is borderline, perform ACTH stimulation test (Synacthen test): 0.25 mg IM or IV with peak serum cortisol <500 nmol/L diagnostic of PAI 1

The mortality risk of untreated adrenal crisis is extremely high, making this the absolute priority diagnosis to pursue in any patient with hyperpigmentation and diarrhea.

References

Research

Cronkhite-Canada Syndrome Presenting as Diarrhea and Weight Loss: A Case Report and Literature Review.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2025

Research

Chronic diarrhea and skin hyperpigmentation: a new association.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 2008

Related Questions

What are the possible causes, recommended evaluation, and treatment options for dark pigmentation on the back?
What are the possible causes of a pigmented band on the nose?
What are the possible causes of small hypopigmented macules on the face, chest, and back?
Can sun exposure cause hypopigmentation?
In an adult without melasma, active dermatitis, pregnancy, or known hypersensitivity, can I safely continue hair dyeing while treating hair‑dye‑induced hyperpigmentation with a hydroquinone‑tretinoin‑fluocinolone regimen and daily broad‑spectrum sunscreen?
What is the appropriate management for a 36-year-old woman with new marked leukocytosis (WBC 22.1 ×10⁹/L, absolute neutrophil count 17.0 ×10⁹/L), thrombocytosis (platelets 572 ×10⁹/L), mild hypokalemia (potassium 3.4 mmol/L), low bicarbonate (CO₂ 19 mmol/L), elevated alkaline phosphatase (159 U/L), dyslipidemia (LDL 143 mg/dL, HDL 39 mg/dL, total cholesterol 204 mg/dL), vitamin D insufficiency (24.4 ng/mL), and well‑controlled type 2 diabetes (A1c 5.3 %)?
Can a mastectomy result in chest wall neuropathy?
A patient with bipolar II disorder and high anxiety who is currently taking quetiapine (Seroquel) and lurasidone (Latuda) – should lithium be added?
In an elderly patient taking amiodarone, what baseline and periodic monitoring tests (e.g., chest X‑ray, pulmonary function tests, thyroid‑stimulating hormone level, liver‑function tests, electrolytes, renal function, 12‑lead ECG, and eye examination) should be performed?
What is the most appropriate pharmacologic sleep aid for a 79-year-old patient?
Can the fifth weekly cisplatin dose (40 mg/m²) be administered in head and neck cancer radiochemotherapy when the platelet count has fallen from 185 × 10⁹/L to 100 × 10⁹/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.